Workers pack boxes containing vials of Covishield, a version of the AstraZeneca vaccine, at the Serum Institute of India in Pune. Photo: AP
Workers pack boxes containing vials of Covishield, a version of the AstraZeneca vaccine, at the Serum Institute of India in Pune. Photo: AP

Explainer |
Why is India facing a coronavirus vaccine crunch and can it ramp up production?

  • India’s major players making vaccines include the Serum Institute of India, Bharat Biotech, Dr Reddy’s, Biological E and Cadila Healthcare
  • But a cash crunch, supply chain issues, second wave of infections and lockdowns have left the world’s largest vaccine producing nation struggling to meet demand

Topic |   Coronavirus pandemic
Workers pack boxes containing vials of Covishield, a version of the AstraZeneca vaccine, at the Serum Institute of India in Pune. Photo: AP
Workers pack boxes containing vials of Covishield, a version of the AstraZeneca vaccine, at the Serum Institute of India in Pune. Photo: AP
READ FULL ARTICLE